This invention provides vaccines comprising an adjuvant and recombinant Herpes Simplex Virus (HSV) glycoproteins consisting of a gD protein and a gE protein; and methods of vaccinating a subject against HSV and treating, impeding, inhibiting, reducing the incidence of, or suppressing an HSV infection or a symptom or manifestation thereof, comprising administration of a vaccine of the present invention.